top of page
Main Product Candidates
NK Cell Therapy Pipeline
Cell Therapy
Indication
Concept
In vitro R&D
Mouse models
Physician sponsored first-in-human
Preclinical
Phase 1/2A
Pivotal Phase 2b
SNK-003
sarcoma
In discussions
Solid tumors
melanoma
Solid tumors
SNK-003
bottom of page